Immunohistochemistry for CDX-2, cytokeratin 7 and 20, CEA, CA125, and Her-2/neu in distinction of metastatic carcinoma in the ovary from primary ovarian carcinoma: A tissue microarray study

被引：0

作者：

Kim, MJ ^{[1
]}

Bae, YK ^{[1
]}

Choi, JH ^{[1
]}

机构：

[1] Yeungnam Univ, Coll Med, Taegu, South Korea

来源：

MODERN PATHOLOGY | 2005年 / 18卷

关键词：

D O I：

暂无

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

875

引用

页码：188A / 188A

页数：1

共 18 条

[1] Immunohistochemistry for CDX-2, cytokeratin 7 and 20, CEA, CA1 25, and Her-2/neu in distinction of metastatic carcinoma in the ovary from primary ovarian carcinoma: A tissue microarray study
Kim, MJ
Bae, YK
Choi, JH
LABORATORY INVESTIGATION, 2005, 85 : 188A - 188A
[2] The usefulness of CDX-2 for differentiating primary and metastatic ovarian carcinoma: An immunohistochemical study using a tissue Microarray
Kim, MJ
JOURNAL OF KOREAN MEDICAL SCIENCE, 2005, 20 (04) : 643 - 648
[3] Her-2/neu amplification in the metastatic breast carcinomas from patients with Her-2/neu overexpressing or nonexpressing primary carcinoma.
Xu, RL
Perle, A
Inghirami, G
Chan, W
Delgado, Y
Feiner, H
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 114 (04) : 656 - 657
[4] Primary Ovarian Carcinoid Tumors may Express CDX-2: A Potential Pitfall in Distinction From Metastatic Intestinal Carcinoid Tumors Involving the Ovary
Rabban, Joseph T.
Lerwill, Melinda F.
McCluggage, W. Glenn
Grenert, James P.
Zaloudek, Charles J.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2009, 28 (01) : 41 - 48
[5] CDX2 versus CK20 and CK7 for distinction of primary ovarian mucinous tumors from metastatic mucinous carcinomas involving the ovary
Vang, R
Gown, AM
Barry, TS
Wheeler, D
Ronnett, B
MODERN PATHOLOGY, 2005, 18 : 207A - 207A
[6] CDX2 versus CK20 and CK7 for distinction of primary ovarian mucinous tumors from metastatic mucinous carcinomas involving the ovary
Vang, R
Gown, AM
Barry, TS
Wheeler, D
Ronnett, B
LABORATORY INVESTIGATION, 2005, 85 : 207A - 207A
[7] Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma - From the Danish "MALOVA" ovarian cancer study
Hogdall, EVS
Christensen, L
Kjaer, SK
Blaakaer, J
Bock, JE
Glud, E
Norgaard-Pederson, B
Hogdall, CK
CANCER, 2003, 98 (01) : 66 - 73
[8] CK7, CK20, CDX2 and MUC2 Immunohistochemical Staining Used To Distinguish Metastatic Colorectal Carcinoma Involving Ovary from Primary Ovarian Mucinous Adenocarcinoma
Shin, Jung Ha
Bae, Jeong Hoon
Lee, Ahwon
Jung, Chan-Kwon
Yim, Hyeon Woo
Park, Jong-Sup
Lee, Kyo-Young
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (03) : 208 - 213
[9] Scoring with MUC2, MUC5, CK7, CK20, CDX2, CEA Immunohistochemical Staining Results Can Be Useful in Identifying Metastatic Colorectal Carcinoma Involving Ovary from Primary Ovarian Mucinous Adenocarcinoma
Shin, J. H.
Jung, C. K.
Lee, A.
Jung, E. S.
Choi, Y. J.
Lee, K. Y.
MODERN PATHOLOGY, 2009, 22 : 237A - 237A
[10] Scoring with MUC2, MUC5, CK7, CK20, CDX2, CEA Immnohistochemical Staining Results Can Be Useful in Identifying Metastatic Colorectal Carcinoma Involving Ovary from Primary Ovarian Mucinous Adenocarcinoma
Shin, J. H.
Jung, C. K.
Lee, A.
Jung, E. S.
Choi, Y. J.
Lee, K. Y.
LABORATORY INVESTIGATION, 2009, 89 : 237A - 237A

← 1 2 →